Data / Public companies / New Jersey / Princeton
Princeton, New Jersey: 16 companies that file annual reports with the SEC
16 companies that file annual reports with the SEC have a business address in Princeton, New Jersey, in the SEC Financial Statement Data Sets filed through September 30, 2026. 9 report revenue, a combined $55.28 billion. 40.0% of the 15 that report net income show a profit. The largest by revenue is Bristol Myers Squibb Co ($48.19 billion).
SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.
- 16Companies with an annual report in the data
- 9Companies that report revenue
- $55.28 billionCombined revenue
- $1.36 billionMedian revenue
- 6 of 15 (40.0%)Reported a net profit
- $136.45 billionCombined total assets
- 5Large accelerated filers
- June 18, 2026Newest annual report filed
Largest by revenue
Latest fiscal year, from each company's annual report. Each name links to the company's page.
| Company | Business address | Revenue | Net income | Total assets | Revenue change |
|---|---|---|---|---|---|
| Bristol Myers Squibb Co | Princeton, NJ | $48.19 billion | $7.05 billion | $90.04 billion | -0.2% |
| Integra Lifesciences Holdings Corp | Princeton, NJ | $1.64 billion | $-516,474,000 | $3.60 billion | 1.5% |
| Clearway Energy, Inc. | Princeton, NJ | $1.43 billion | $169 million | $16.66 billion | 4.2% |
| Clearway Energy LLC | Princeton, NJ | $1.43 billion | $384 million | $16.44 billion | 4.2% |
| Miami International Holdings, Inc. | Princeton, NJ | $1.36 billion | $-70,029,000 | $1.26 billion | 19.6% |
| Amicus Therapeutics, Inc. | Princeton, NJ | $634.2 million | $-27,110,000 | $949.9 million | 20% |
| Essential Properties Realty Trust, Inc. | Princeton, NJ | $561.2 million | $253 million | $6.86 billion | 24.8% |
| Cytosorbents Corp | Princeton, NJ | $37.1 million | $-8,198,000 | $44.2 million | 4.1% |
| Sonnet Biotherapeutics Holdings, Inc. | Princeton, NJ | $1 million | $-16,011,487 | $14.9 million | 5,268.8% |
Companies by size of revenue
Companies that report revenue, by the revenue in their latest annual report.
| Revenue | Companies | Share |
|---|---|---|
| Under $10 million | 1 | 11.1% |
| $10 million to $100 million | 1 | 11.1% |
| $100 million to $1 billion | 2 | 22.2% |
| $1 billion to $10 billion | 4 | 44.4% |
| $10 billion and over | 1 | 11.1% |
Industries with the most companies
By the SEC's Standard Industrial Classification (SIC) code of the company.
| Industry | Companies | Share | Combined revenue |
|---|---|---|---|
| Pharmaceutical preparations | 7 | 43.8% | $48.83 billion |
| Blank checks | 3 | 18.8% | $0 |
| Surgical and medical instruments and apparatus | 2 | 12.5% | $1.67 billion |
| Electric services | 2 | 12.5% | $2.86 billion |
| Security brokers, dealers and flotation companies | 1 | 6.2% | $1.36 billion |
| Real estate investment trusts | 1 | 6.2% | $561.2 million |
Newest annual reports
By the date the company filed its latest annual report with the SEC.
| Company | Filed | Fiscal year ended | Form | Revenue |
|---|---|---|---|---|
| Grace Therapeutics, Inc. | June 18, 2026 | March 31, 2026 | 10-K | Not listed |
| Soligenix, Inc. | March 31, 2026 | December 31, 2025 | 10-K | Not listed |
| PDS Biotechnology Corp | March 30, 2026 | December 31, 2025 | 10-K | Not listed |
| Cytosorbents Corp | March 30, 2026 | December 31, 2025 | 10-K | $37.1 million |
| Space Asset Acquisition Corp. | March 27, 2026 | December 31, 2025 | 10-K | Not listed |
| PMV Pharmaceuticals, Inc. | March 6, 2026 | December 31, 2025 | 10-K | Not listed |
| Miami International Holdings, Inc. | March 6, 2026 | December 31, 2025 | 10-K | $1.36 billion |
| Digital Asset Acquisition Corp. | March 3, 2026 | December 31, 2025 | 10-K | Not listed |
| Real Asset Acquisition Corp. | March 3, 2026 | December 31, 2025 | 10-K | Not listed |
| Integra Lifesciences Holdings Corp | February 26, 2026 | December 31, 2025 | 10-K | $1.64 billion |
| Clearway Energy LLC | February 24, 2026 | December 31, 2025 | 10-K | $1.43 billion |
| Clearway Energy, Inc. | February 24, 2026 | December 31, 2025 | 10-K | $1.43 billion |
Filer category
The SEC's size class for the company when it filed.
| Category | Companies | Share |
|---|---|---|
| Non-accelerated filer | 11 | 68.8% |
| Large accelerated filer | 5 | 31.2% |
Updated September 30, 2026. Read from SEC Financial Statement Data Sets (sec.gov). Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.